These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

127 related items for PubMed ID: 3925170

  • 1. An in vivo assessment of factor VIII concentrates.
    Rock G, Tittley P, Fuller V.
    JAMA; 1985 Aug 09; 254(6):777-80. PubMed ID: 3925170
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Studies on the response of patients with classic hemophilia to transfusion with concentrates of antihemophilic factor. A difference in the half-life of antihemophilic factor as measured by procoagulant and immunologic techniques.
    Bennett B, Ratnoff OD.
    J Clin Invest; 1972 Oct 09; 51(10):2593-6. PubMed ID: 4626847
    [Abstract] [Full Text] [Related]

  • 5. [Hemostatic management in hemophilia A. Usefulness of APTT and TEG as a method for monitoring Factor VIII concentrates].
    Watanabe S, Ito S, Igarashi S, Itamoto M, Harada N, Kanazawa M, Sato M, Yasukouji T.
    Shoni Shikagaku Zasshi; 1985 Oct 09; 23(3):760-8. PubMed ID: 3938858
    [No Abstract] [Full Text] [Related]

  • 6. In vivo recovery of factor VIII: a comparison of one-stage and two-stage assay methods.
    Nilsson IM, Kirkwood TB, Barrowcliffe TW.
    Thromb Haemost; 1979 Dec 21; 42(4):1230-9. PubMed ID: 120619
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Analytic variability due to change of deficient plasma vials: application to one-stage clotting factor VIII assay.
    Nougier C, Sobas F, Nguyen TK, Carage ML, Lienhart A, Négrier C.
    Blood Coagul Fibrinolysis; 2011 Mar 21; 22(2):151-4. PubMed ID: 21192255
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Clearance of cryoprecipitated factor VIII in canine hemophilia A.
    Aufderheide WM, Skinner SF, Kaneko JJ.
    Am J Vet Res; 1975 Apr 21; 36(4 Pt.1):367-70. PubMed ID: 1124873
    [Abstract] [Full Text] [Related]

  • 12. [Current clinical aspects in hemophilia treatment].
    Meili EO.
    Schweiz Med Wochenschr; 1989 Sep 30; 119(39):1332-41. PubMed ID: 2508219
    [Abstract] [Full Text] [Related]

  • 13. Discrepancies in measured factor VIII activity in patients treated with factor VIII concentrate of human or porcine origin.
    Teitel JM, Lau HK, Garvey MB.
    Thromb Haemost; 2002 Jul 30; 88(1):159-60. PubMed ID: 12152659
    [No Abstract] [Full Text] [Related]

  • 14. The treatment of classical hemophilia with factor 8 concentrates.
    Waterbury L, Frenkel EP.
    Clin Anesth; 1968 Jul 30; 3():288-97. PubMed ID: 4902367
    [No Abstract] [Full Text] [Related]

  • 15. Kinetic analysis of bovine factor VIII in the hemophilic dog.
    Gentry PA, Kirby EP, Gentry RD.
    Thromb Haemost; 1981 Aug 28; 46(2):485-8. PubMed ID: 6795739
    [Abstract] [Full Text] [Related]

  • 16. Factor VIII half-life and clinical phenotype of severe hemophilia A.
    van Dijk K, van der Bom JG, Lenting PJ, de Groot PG, Mauser-Bunschoten EP, Roosendaal G, Grobbee DE, van den Berg HM.
    Haematologica; 2005 Apr 28; 90(4):494-8. PubMed ID: 15820945
    [Abstract] [Full Text] [Related]

  • 17. Lyophilized cryoprecipitate for children with hemophilia A.
    Nuchprayoon I, Sahasittiwat S, Kittikalayawong A, Chantanakajornfung A.
    J Med Assoc Thai; 2002 Jun 28; 85 Suppl 1():S293-7. PubMed ID: 12188426
    [Abstract] [Full Text] [Related]

  • 18. Coincident classic hemophilia and "idiopathic" thrombocytopenic purpura in patients under treatment with concentrates of antihemophilic factor (factor VIII).
    Ratnoff OD, Menitove JE, Aster RH, Lederman MM.
    N Engl J Med; 1983 Feb 24; 308(8):439-42. PubMed ID: 6401839
    [No Abstract] [Full Text] [Related]

  • 19. Factor VIII: C (FVIII: C) recovery and half-life after infusion of steam-treated high purity factor VIII concentrate in severe hemophilia A--comparison of one-stage assay, two-stage assay and a chromogenic substrate assay.
    Hellstern P, Kiehl R, Miyashita C, Schwerdt H, von Blohn G, Köhler M, Büttner M, Wenzel E.
    Thromb Haemost; 1986 Dec 15; 56(3):353-9. PubMed ID: 3105109
    [Abstract] [Full Text] [Related]

  • 20. Survival of transfused factor VIII in hemophilic patients treated with epsilon aminocaproic acid.
    Weiss AE, Webster WP, Strike LE, Brinkhous KM.
    Transfusion; 1976 Dec 15; 16(3):209-14. PubMed ID: 936268
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.